From the *Department of Medical Oncology, Dana-Farber Cancer Institute;
†Department of Pathology, Brigham and Women's Hospital;
‡Center for Cancer Genome Discovery,
§Molecular Biology Core Facilities, and
∥Department of Pathology, Dana-Farber Cancer Institute; and
¶Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA.
Received for publication January 25, 2018; accepted July 14, 2018.
Address correspondence to: Matthew H. Kulke, MD, Section of Hematology and Oncology, Boston University and Boston Medical Center, 820 Harrison Ave, Boston MA 02118 (e-mail: [email protected]).
The authors declare no conflict of interest.
This study was supported in part by a grant from the NET Research Foundation to M.H.K. This study was also supported by US National Institutes of Health (NIH) grants R01 CA151532 to M.H.K., R01 CA151993 to S.O., and R35 CA197735 to S.O.
